首页|期刊导航|Oncology Research|BCL2-Associated Transcription Factor 1 Promotes SRC/Hypoxia-Inducible Factor 1 Subunit α-Mediated Cancer Stemness in Radioresistant Triple-Negative Breast Cancer

BCL2-Associated Transcription Factor 1 Promotes SRC/Hypoxia-Inducible Factor 1 Subunit α-Mediated Cancer Stemness in Radioresistant Triple-Negative Breast CancerOA

中文摘要

Backgrounds:Triple-negative breast cancer(TNBC)is highly aggressive,insensitive to radiotherapy,and exhibits increased cancer stem cell(CSC)properties,contributing to poor patient outcomes.B-cell lymphoma 2(BCL2)associated transcription factor 1(BCLAF1)is an oncogene in certain cancers,but its role in TNBC is unclear.This study investigated BCLAF1’s involvement in radioresistance and CSC activity in TNBC.Methods:BCLAF1 expression and clinical significance were analyzed using The Cancer Genome Atlas(TCGA)breast cancer dataset.Radioresistant MDA-MB-231 cells were used to examine BCLAF1’s function.Proto-oncogene SRC(SRC)overexpression,BCLAF1 knockdown,dasatinib treatment,and hypoxia inducible factor 1 subunitα(HIF-1α)inhibition were employed to elucidate regulatory mechanisms.CSC activity was assessed using tumorsphere formation assays.Results:Elevated BCLAF1 mRNA levels were associated with advanced pathological and T stages(analysis of variance[ANOVA],p=1.4×10^(−3))and poorer overall survival by Kaplan–Meier analysis(p=0.021).BCLAF1 expression was positively correlated with SRC signaling pathway-associated genes,including Kirsten rat sarcoma viral oncogene homolog(KRAS),GTPase-activating protein-binding protein 1(G3BP1),and phosphoinositide-3-kinase regulatory subunit 1(PIK3R1).Radioresistant cells exhibited higher BCLAF1 expression.SRC overexpression reduced radiosensitivity,while increasing BCLAF1 levels.BCLAF1 knockdown suppressed tumorsphere formation.Dasatinib decreased BCLAF1,HIF-1α,and stemness proteins,including octamer-binding transcription factor 4(OCT-4),Notch intracellular domain(NICD),and cellular myelocytomatosis oncogene(c-Myc).BCLAF1 knockdown diminished nuclear HIF-1α,and HIF-1αinhibition abrogated BCLAF1-induced tumorsphere formation.Conclusions:BCLAF1 enhances radioresistance and CSC properties in TNBC via SRC-HIF-1αsignaling,suggesting that BCLAF1 is a potential therapeutic target to overcome radioresistance in TNBC.

Yu-Hao Huang;Hao-Yeh Chen;Peng-Ju Chien;Chun-Yu Chen;Shao-Ti Li;Hsueh-Te Lee;Yueh-Chun Lee;Wen-Wei Chang

Department of Biomedical Sciences,Chung Shan Medical University,Taichung,Taiwan,ChinaDepartment of Emergency Medicine,Tungs’Taichung MetroHarbor Hospital,Taichung,Taiwan,ChinaDepartment of Biomedical Sciences,Chung Shan Medical University,Taichung,Taiwan,ChinaDepartment of Emergency Medicine,Tungs’Taichung MetroHarbor Hospital,Taichung,Taiwan,China Post-Baccalaureate Medicine,Chung Hsing University,Taichung,Taiwan,ChinaDepartment of Radiation Oncology,Chung Shan Medical University Hospital,Taichung,Taiwan,ChinaInstitute of Anatomy&Cell Biology,College of Medicine,Yang Ming Chiao Tung University,Taipei,Taiwan,ChinaDepartment of Radiation Oncology,Chung Shan Medical University Hospital,Taichung,Taiwan,China School of Medicine,Chung Shan Medical University,Taichung,Taiwan,ChinaDepartment of Biomedical Sciences,Chung Shan Medical University,Taichung,Taiwan,China Department of Medical Research,Chung Shan Medical University Hospital,Taichung,Taiwan,China

医药卫生

B-cell lymphoma 2(BCL2)associated transcription factor 1SRC kinasehypoxia-inducing factor 1subunitαtriple negative breast cancercancer stemnessradiation response

《Oncology Research》 2026 (7)

P.465-483,19

supported by Chung Shan Medical University Hospital,Taiwan(Yueh-Chun Lee,grant No.CSH-2021-C-027)by the National Science and Technology Council(Wen-Wei Chang,grant No.114-2320-B-040-005-MY3).

10.32604/or.2026.080978

评论